Skip to main content
Top
Published in: Medical Oncology 4/2008

01-12-2008 | Case

Nephrotic syndrome and acute renal failure in non-Hodgkin lymphoplasmacytic lymphoma

Authors: Nataša Čolović, Tatjana Terzić, Boško Anđelić, Mirjana Sretenović, Biljana Mihaljević, Jasmina Marković Lipkovski, Milica Čolović

Published in: Medical Oncology | Issue 4/2008

Login to get access

Abstract

Two patients with lymphoplasmacytic lymphoma, and monoclonal proteins of IgM in one, and IgG and lambda light chains in the second patient, nephrotic syndrome and acute renal failure are reported. A 58-year-old man previously treated for pre-B acute lymphoblastic leukemia, developed 3 years later nephrotic syndrome as a complication of lymphoplasmacytic lymphoma and high-paraprotein IgM kappa type. Immunofluorescent analysis of kidney biopsy showed extensive IgM and light kappa chain deposits, which caused membranoproliferative glomerulonephritis. Treatment with cyclophosphamide was ineffective and patient died 2 months later. The second patient is a 42-year-old female diagnosed with lymphoplasmacytic lymphoma and paraprotein IgG lambda type. The course of the disease was fulminant with developing nephrotic syndrome and fatal acute renal failure. Immunofluorescent and light microscopic studies of kidney biopsy showed signs of immunotactoid glomerulonephritis with deposits of IgG and C3. Hemodyalises and cytostatic therapy were without response and she died after 45 days.
Literature
1.
go back to reference Markowitz GS, Zdunek MP, D’Agati VD. Nephrotic syndrome, renal insufficiency and a monoclonal gammopathy. Am J Kid Dis 2001;38:1135–40.PubMedCrossRef Markowitz GS, Zdunek MP, D’Agati VD. Nephrotic syndrome, renal insufficiency and a monoclonal gammopathy. Am J Kid Dis 2001;38:1135–40.PubMedCrossRef
2.
go back to reference Nasr SH, Markowitz GS, Stokes MB, Seshan SV, Valderrama E, Appel GB, Aucouturier P, D’Agati VD. Proliferative glomerulonephritis with monoclonal IgG deposists: a distinct entity mimicking immune-complex glomerulonephritis. Kidney Int 2004;65:85–96.PubMedCrossRef Nasr SH, Markowitz GS, Stokes MB, Seshan SV, Valderrama E, Appel GB, Aucouturier P, D’Agati VD. Proliferative glomerulonephritis with monoclonal IgG deposists: a distinct entity mimicking immune-complex glomerulonephritis. Kidney Int 2004;65:85–96.PubMedCrossRef
3.
go back to reference Morel-Maroger L, Basch A, Dannon F, et al. Pathology of the kidney in Waldenstrom’s macroglobulinemia. Study of sixteen cases. N Engl J Med 1970;283:123–9.PubMedCrossRef Morel-Maroger L, Basch A, Dannon F, et al. Pathology of the kidney in Waldenstrom’s macroglobulinemia. Study of sixteen cases. N Engl J Med 1970;283:123–9.PubMedCrossRef
4.
go back to reference Lindstrom FD, Hed J, Enestorm S. Renal pathology of Waldenstrom’s macroglobulinemia with monoclonal antiglomerular antibodies and nephrotic syndrome. Clin Exp Immunol 1980;41:196–204.PubMed Lindstrom FD, Hed J, Enestorm S. Renal pathology of Waldenstrom’s macroglobulinemia with monoclonal antiglomerular antibodies and nephrotic syndrome. Clin Exp Immunol 1980;41:196–204.PubMed
6.
go back to reference Martelo OJ, Schultz DR, Pardo V, Perez-stable E. Immunologically-mediated renal disease in Waldenstrom’s macroglobulinemia. Am J Med 1975;58:567–75.PubMedCrossRef Martelo OJ, Schultz DR, Pardo V, Perez-stable E. Immunologically-mediated renal disease in Waldenstrom’s macroglobulinemia. Am J Med 1975;58:567–75.PubMedCrossRef
Metadata
Title
Nephrotic syndrome and acute renal failure in non-Hodgkin lymphoplasmacytic lymphoma
Authors
Nataša Čolović
Tatjana Terzić
Boško Anđelić
Mirjana Sretenović
Biljana Mihaljević
Jasmina Marković Lipkovski
Milica Čolović
Publication date
01-12-2008
Publisher
Humana Press Inc
Published in
Medical Oncology / Issue 4/2008
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-008-9048-0

Other articles of this Issue 4/2008

Medical Oncology 4/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.